Lupride Depot 45 mg Injection: Uses, Benefits, Side Effects & Safety Information

Lupride Depot 45 mg Injection is a prescription hormonal medicine containing leuprolide acetate, a synthetic analogue of gonadotropin-releasing hormone (GnRH). The product shown is a depot formulation designed for prolonged drug release. Leuprolide belongs to a group of medicines known as GnRH agonists.

Lupride Depot 45 mg is used in hormone-dependent medical conditions, particularly advanced prostate cancer. Leuprolide products in other strengths and formulations may also be prescribed for conditions such as endometriosis, uterine fibroids, or certain forms of early puberty; however, the approved indication depends on the specific formulation and prescribing information. The FDA-approved 45 mg six-month leuprolide depot formulation is indicated for advanced prostate cancer.

Because Lupride Depot is a prescription injection that changes hormone activity, it should only be used when prescribed and administered under appropriate medical supervision.

What Is Lupride Depot 45 mg Injection?

Lupride Depot 45 mg contains leuprolide acetate 45 mg. It is a long-acting GnRH agonist that affects the body’s production of reproductive hormones.

The medicine initially stimulates GnRH receptors. With continued exposure, these receptors become less responsive, resulting in suppression of signals that normally stimulate the production of sex hormones. In men with hormone-sensitive prostate cancer, this ultimately lowers testosterone levels, which can slow the growth or progression of prostate cancer that depends on androgen signaling.

The 45 mg depot formulation is designed as a six-month formulation, with the corresponding FDA-approved leuprolide 45 mg depot administered every 24 weeks by a healthcare professional. The exact regimen for a branded product should always be confirmed from its local prescribing information.

Current Indian pharmacy listings identify Sun Pharmaceutical Industries Ltd. as the manufacturer/marketer of Lupride Depot 45 mg Injection.

Uses of Lupride Depot 45 mg

The principal established use of the 45 mg six-month leuprolide depot formulation is:

• Management of advanced prostate cancer, as part of hormone-based cancer treatment.

Leuprolide works by reducing testosterone production, which can help control hormone-dependent prostate cancer.

Other leuprolide formulations have different approved uses. Therefore, information about another leuprolide strength should not automatically be applied to Lupride Depot 45 mg.

This medicine should only be used under the supervision of a qualified healthcare professional.

Benefits of Lupride Depot 45 mg

The potential benefits of Lupride Depot 45 mg are related to its ability to suppress hormone activity involved in the growth of hormone-dependent prostate cancer.

Potential clinical benefits may include:

• Helps reduce testosterone stimulation of prostate cancer cells.
• Supports hormonal management of advanced prostate cancer.
• Provides prolonged hormone suppression through a depot formulation.
• May help control disease-related symptoms when incorporated into an appropriate treatment plan.
• Can form part of long-term cancer management under specialist supervision.

Lupride Depot is not a guaranteed cure for cancer. Treatment response varies between individuals, and doctors may use it alongside other cancer treatments depending on the patient’s condition.

How Does Lupride Depot 45 mg Work?

Leuprolide is a GnRH agonist.

Normally, GnRH signaling stimulates the pituitary gland to release hormones that encourage the testes to produce testosterone. When leuprolide is given continuously through a depot formulation, this signaling pathway becomes suppressed.

As a result:

1. GnRH receptors are initially stimulated.
2. Continued stimulation reduces pituitary responsiveness.
3. Production of luteinizing hormone decreases.
4. Testosterone production in the testes falls substantially.
5. Reduced testosterone can decrease hormonal stimulation of prostate cancer.

An important point is that testosterone can temporarily rise during the early period after treatment begins. This phenomenon is commonly referred to as tumor flare and requires appropriate medical monitoring, particularly in patients with advanced disease.

Lupride Depot 45 mg Dosage and Administration

Lupride Depot 45 mg is a prescription depot injection and should not be self-administered.

The appropriate treatment schedule depends on the patient’s diagnosis, overall health, previous treatment, and the specific product formulation. The FDA-approved leuprolide 45 mg six-month depot formulation is administered by a healthcare professional at 24-week intervals.

Patients should:

• Follow the treatment plan provided by their specialist.
• Never change the treatment schedule independently.
• Not attempt to inject the medicine themselves.
• Tell their healthcare provider about other medicines and medical conditions.
• Attend scheduled follow-up appointments and laboratory monitoring.

The term Lupride Depot 45 mg dosage should therefore be understood as a prescription-specific medical decision rather than a standard self-treatment instruction.

Side Effects of Lupride Depot 45 mg

Like all medicines, Lupride Depot 45 mg may cause side effects, although not everyone experiences them.

Common Side Effects

Possible adverse effects associated with leuprolide therapy include:

• Hot flushes or sweating
• Fatigue or tiredness
• Injection-site pain or discomfort
• Headache
• Changes in body weight
• Reduced sexual interest
• Erectile or sexual-function changes
• Mood changes
• Joint or muscle discomfort

Hot flushes, injection-site discomfort and fatigue are among adverse reactions reported with the 45 mg six-month leuprolide depot formulation.

Serious Side Effects

Patients should seek prompt medical attention if they experience symptoms suggesting a serious reaction, such as:

• Severe allergic reaction
• Significant worsening of prostate-cancer-related symptoms after treatment begins
• New or severe neurological symptoms
• Symptoms suggestive of abnormal heart rhythm
• Severe skin reactions
• Seizures
• Symptoms of significant cardiovascular problems

Leuprolide therapy has important warnings involving tumor flare, metabolic changes, cardiovascular risk, QT-interval effects, seizures, and rare severe skin reactions.

If side effects persist or become severe, contact your healthcare provider promptly.

Warnings and Precautions

Before treatment with Lupride Depot 45 mg, the healthcare professional should know about the patient’s medical history.

Cardiovascular Health

GnRH agonists have been associated with cardiovascular risks in men, including myocardial infarction, sudden cardiac death and stroke. Patients with cardiovascular risk factors may require appropriate monitoring.

Blood Sugar and Metabolic Health

Leuprolide treatment may contribute to metabolic changes such as increased blood glucose, diabetes and changes in blood lipids. Appropriate monitoring may therefore be recommended during long-term therapy.

Heart Rhythm

Androgen-deprivation therapy may affect the QT/QTc interval. Patients with relevant heart-rhythm risks should discuss them with their healthcare provider.

Tumor Flare

Testosterone can temporarily increase after treatment begins. In some patients with advanced prostate cancer, this can temporarily worsen symptoms. Close medical observation is particularly important when there are vertebral lesions or urinary obstruction.

Pregnancy

Leuprolide can cause fetal harm and is not a medicine to be used during pregnancy unless specifically directed in an appropriate specialist setting. People who could become pregnant should discuss pregnancy status and contraception with their healthcare professional.

Liver and Kidney Conditions

Tell the doctor about existing liver or kidney problems. The healthcare professional can determine whether additional monitoring or treatment considerations are necessary.

Allergies

Lupride Depot should not be used by someone with a known serious hypersensitivity to GnRH agonists or relevant ingredients.

Drug Interactions

Leuprolide may interact with other medicines or affect the risk associated with certain treatments.

Before receiving Lupride Depot 45 mg, inform the healthcare professional about:

• Prescription medicines
• Over-the-counter medicines
• Vitamins
• Herbal products
• Medicines affecting heart rhythm
• Medicines used for diabetes or cardiovascular conditions

Patients should provide a complete medication list so that potential interactions and overlapping risks can be assessed.

Storage Instructions

Storage requirements can depend on the specific branded formulation and its packaging instructions.

Generally:

• Keep the medicine in its original packaging.
• Protect it from inappropriate temperatures, excessive heat and direct sunlight.
• Follow the storage conditions printed on the product packaging.
• Keep it away from children.
• Do not use the product after its expiry date.
• Do not use a damaged or compromised package.

Healthcare facilities and pharmacies should follow the manufacturer’s storage requirements for the specific product.

Lupride Depot 45 mg Price

The Lupride Depot 45 mg price can vary depending on the pharmacy, location, taxes, discounts, availability and current manufacturer pricing. Online listings can change over time, so a displayed price should not be treated as a fixed national price.

Since Lupride Depot 45 mg is a prescription medicine, purchase and use should follow applicable medical and pharmacy requirements.

Lupride Depot 45 mg Manufacturer

Current Indian pharmacy listings identify Sun Pharmaceutical Industries Ltd. as the manufacturer/marketer of Lupride Depot 45 mg Injection. Product packaging and local regulatory information should be checked for the most current manufacturer and batch details.

Frequently Asked Questions

1. What is Lupride Depot 45 mg used for?

Lupride Depot 45 mg contains leuprolide acetate, a GnRH agonist. The 45 mg six-month leuprolide depot formulation is used for hormonal management of advanced prostate cancer. It reduces testosterone production after continuous hormonal suppression. The exact indication should always be confirmed for the specific branded product prescribed by the treating specialist.

2. How does Lupride Depot 45 mg work?

It works by altering GnRH signaling. Continuous exposure eventually suppresses pituitary signals responsible for stimulating testosterone production. Lower testosterone reduces hormonal stimulation of prostate cancer cells. Testosterone can temporarily rise at the beginning of therapy, so appropriate clinical monitoring is important.

3. Is Lupride Depot 45 mg safe?

It can be an important treatment when appropriately prescribed, but it is not suitable for everyone. Leuprolide has significant warnings involving metabolic health, cardiovascular risks, tumor flare, heart-rhythm effects and other adverse reactions. A specialist should assess the potential benefits and risks for each patient.

4. Can Lupride Depot 45 mg be used long term?

Long-term hormonal treatment may be appropriate for some patients with advanced prostate cancer. The duration depends on the cancer, treatment response, other therapies and the treating specialist’s plan. Regular medical follow-up is important because prolonged androgen suppression can produce ongoing adverse effects and metabolic changes.

5. What happens if a scheduled injection is missed?

Patients should not attempt to compensate for a missed treatment independently. Contact the treating healthcare provider as soon as possible for guidance regarding the treatment schedule. Keeping scheduled oncology appointments is important for maintaining the intended treatment plan.

6. Can Lupride Depot 45 mg be stopped suddenly?

Patients should not independently stop or alter prescribed hormonal cancer therapy. The decision to discontinue, postpone or change treatment should be made by the treating specialist after considering the cancer status, treatment response and alternative management options.

7. Can Lupride Depot 45 mg be taken with food?

Lupride Depot 45 mg is a depot injection rather than an oral medicine, so food does not determine its administration in the same way it does for tablets or capsules. The injection must be administered according to the product’s prescribing information by an appropriate healthcare professional.

8. What are the common Lupride Depot 45 mg side effects?

Commonly reported effects associated with the 45 mg six-month leuprolide depot formulation include hot flushes, injection-site discomfort and fatigue. Other hormone-related effects may occur. Patients should discuss persistent, troublesome or unexpected symptoms with their healthcare provider.

9. Who should avoid Lupride Depot 45 mg?

People with known serious hypersensitivity to GnRH agonists or relevant ingredients should not receive the medicine. Special consideration may also be necessary for people with cardiovascular disease, metabolic disorders, heart-rhythm concerns, seizure history or other significant medical conditions. A doctor should review the patient’s medical history before treatment.

10. How should Lupride Depot 45 mg be stored?

The product should be stored according to the manufacturer’s instructions printed on its packaging. Keep it protected from inappropriate temperatures, direct sunlight and children. Pharmacies and healthcare facilities should follow the product-specific storage requirements and should not use expired or damaged products.

Disclaimer

This article is provided for general educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Lupride Depot 45 mg is a prescription medicine and should only be used when prescribed by a qualified healthcare professional.

Do not self-medicate, self-inject, change the treatment schedule or discontinue prescribed cancer therapy without medical advice. Individual responses to leuprolide can vary, and the appropriate treatment plan depends on the patient’s diagnosis, medical history, other medicines and clinical condition.